Fundamental analysis · SEC EDGAR · TTM through 31/03/2026
HCA · NYSE · Healthcare
Fundamental quality
66
out of 100
Hca Healthcare, Inc. earns a fundamental-quality score of 66 out of 100, profiling it as a company of reasonable quality. Its score rests mainly on its growth (revenue +7.8%/yr). Whether it's cheap or expensive depends on the current price, which you can compute in the tool.
HCA Healthcare is the largest private hospital network in the U.S.: over 180 hospitals plus thousands of outpatient centers. It makes money on patient volumes and cost management the public sector can't replicate.
EPS growth: 20.5% · Revenue growth: 7.8%
Net margin: 8.9% · ROIC: 23.6%
Net debt/EBITDA: 3x · FCF: 10.4%
Source: SEC EDGAR · TTM through 31/03/2026
The score includes +1 for dividend strength: 5 consecutive years of increases. Keeping that streak demands growing cash generation and balance-sheet discipline.
The score combines growth, profitability and financial strength, and here its pillars hold up evenly.
Percentile against the other 57 Healthcare companies in our coverage: how far it beats them on each metric (100 = best in sector).
Computed from the daily dataset scores. A high percentile places the company among the best in its sector on that metric; it is not a buy recommendation.
Key concepts
What do these metrics mean? Fundamental analysis · What is the P/E · What is EPS · What is ROE · Net & gross margin · Free cash flow
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2020 | 51,533 | 3,754 | 6,397 | 29,211 |
| 2021 | 58,752 | 6,956 | 5,382 | 33,128 |
| 2022 | 60,233 | 5,643 | 4,127 | 37,176 |
| 2023 | 64,968 | 5,242 | 4,687 | 38,658 |
| 2024 | 70,603 | 5,760 | 5,639 | 41,098 |
| 2025 | 75,600 | 6,784 | 7,692 | 45,452 |
Between 2020 and 2025, revenue went from $51,533M to $75,600M (+47%) and net income went from $3,754M to $6,784M (+81%).
Annual figures in millions of U.S. dollars ($M) per SEC filings. Net debt is total debt minus cash.
Latest results
Figures for the quarter ended March 31, 2026, versus the quarter ended March 31, 2025 (SEC filings):
Automatic comparison between the two most recent periods filed with the SEC. One quarter doesn't make a trend: read it alongside the historical evolution above.
$2.88
per share, yearly
10% of earnings
Payout
at least 5 straight years raising it
Growth
That is what we can verify in the SEC filings, whose structured data only starts in 2008 and which many companies begin tagging later. The real streak may be considerably longer.
The dividend yield depends on today's price. Compute it in the analyzer → · See all dividend-paying stocks →
Open your account in minutes with regulated brokers and buy U.S. and European stocks from small amounts. No paperwork.
The serious investor's standard
Open free account →Anyone who wants low commissions and access to almost any market in the world.
Popular in the U.S.
Open free account →Anyone investing in the U.S. who wants a powerful, commission-free stock app.
Investing carries risk of loss.
Is Hca Healthcare, Inc. cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Is Hca Healthcare, Inc. a good company to invest in?
In terms of business quality, Hca Healthcare, Inc. scores 66 out of 100 in our analysis, placing it as a company of reasonable quality. That said, this isn't a recommendation: whether it's a good investment also depends on its current price and your goals.
Is Hca Healthcare, Inc. a profitable company?
Hca Healthcare, Inc. is profitable, with a net margin of 8.9%, though a thin one.
Does Hca Healthcare, Inc. have a lot of debt?
A moderate level: its net debt is 3 times its EBITDA.
Is Hca Healthcare, Inc. growing?
Its revenue has grown 7.8% annualized in recent years and its earnings per share 20.5%, and without interruption since 2020.
Does Hca Healthcare, Inc. generate cash?
Yes. It converts about 10.4% of its revenue into free cash flow, and has done so positively year after year.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
More Healthcare companies
Henry Schein (HSIC) · Brightspring Health Services (BTSG) · Community Health Systems (CYH) · Hims & Hers Health (HIMS) · Oscar Health (OSCR) · Recursion Pharmaceuticals (RXRX) · see more →
The best Healthcare stocks by our model →
Compare Hca Healthcare, Inc. with 500+ companies in the screener →
Who's behind the methodology and model · how the score is computed
Data: see Hca Healthcare, Inc.'s filings on EDGAR
Spotted a figure that looks wrong? Report it and we'll review it.